- Home
- CTSO vs AMLI Comparison
CTSO vs AMLI Comparison
Compare CTSO & AMLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- AMLI
- Stock Information
- Founded
- CTSO 1997
- AMLI 1974
- Country
- CTSO United States
- AMLI Canada
- Employees
- CTSO N/A
- AMLI N/A
- Industry
- CTSO Medical/Dental Instruments
- AMLI Industrial Machinery/Components
- Sector
- CTSO Health Care
- AMLI Industrials
- Exchange
- CTSO Nasdaq
- AMLI Nasdaq
- Market Cap
- CTSO 73.5M
- AMLI 80.7M
- IPO Year
- CTSO N/A
- AMLI N/A
- Fundamental
- Price
- CTSO $1.19
- AMLI $0.55
- Analyst Decision
- CTSO Strong Buy
- AMLI Strong Buy
- Analyst Count
- CTSO 3
- AMLI 1
- Target Price
- CTSO $4.67
- AMLI $3.25
- AVG Volume (30 Days)
- CTSO 118.0K
- AMLI 529.6K
- Earning Date
- CTSO 11-07-2024
- AMLI 10-14-2024
- Dividend Yield
- CTSO N/A
- AMLI N/A
- EPS Growth
- CTSO N/A
- AMLI N/A
- EPS
- CTSO N/A
- AMLI N/A
- Revenue
- CTSO $37,159,990.00
- AMLI N/A
- Revenue This Year
- CTSO $11.14
- AMLI N/A
- Revenue Next Year
- CTSO $17.07
- AMLI N/A
- P/E Ratio
- CTSO N/A
- AMLI N/A
- Revenue Growth
- CTSO 2.17
- AMLI N/A
- 52 Week Low
- CTSO $0.70
- AMLI $0.32
- 52 Week High
- CTSO $2.15
- AMLI $1.35
- Technical
- Relative Strength Index (RSI)
- CTSO 45.86
- AMLI 61.78
- Support Level
- CTSO $1.26
- AMLI $0.51
- Resistance Level
- CTSO $1.59
- AMLI $0.46
- Average True Range (ATR)
- CTSO 0.16
- AMLI 0.05
- MACD
- CTSO -0.03
- AMLI 0.01
- Stochastic Oscillator
- CTSO 14.89
- AMLI 66.33
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About AMLI American Lithium Corp.
American Lithium Corp is an exploration-stage company. It is engaged in the identification, acquisition, and exploration of mineral interests in the United States of America and Peru. Its projects include TLC Lithium, Falchani Lithium, and Macusani Uranium project.